Innovators at these companies trust us

The central challenge in the medical device environment

Medical technology companies today are caught between clinical demands and regulatory rigor: they must deliver innovation while meeting the highest standards for safety, traceability and documentation. Without targeted upskilling, many teams remain uncertain when implementing AI projects — especially on topics like Regulatory Alignment and Safe AI.

Why we have the industry expertise

Our teams combine product thinking with regulatory sensitivity: we come from engineering, deep learning development, and product and quality management, and have supported numerous projects where safety and compliance were integrated into the product architecture from the start. This interplay is essential when AI in medical devices is to be established not just as a proof-of-concept, but as a certified feature.

In enablement we rely on hands-on formats: Executive Workshops for strategic decision-makers, bootcamps for departments and an AI Builder Track that turns less technical employees into productive AI creators. These formats are complemented by Enterprise Prompting Frameworks and playbooks so that what is learned becomes immediately tangible and auditable in daily work.

Our references in this industry

Direct MedTech client names from our portfolio are not always publicly shareable, so we point to transferable projects from adjacent industries where regulatory complexity, clinical users and safety-critical requirements played a central role. In the go-to-market for a new display technology with BOSCH we demonstrated how technical roadmaps can be linked to market approval strategies.

For FMG we implemented an AI-based document search and analysis solution that can be directly transferred to questions around regulatory documentation and evidence generation; such solutions serve as exemplars for documentation copilots and audit support in MedTech. The digital learning platform project with Festo Didactic is another example: here we developed teaching and training formats that are ideal to adapt for MedTech bootcamps and on-the-job coaching.

Our technological transfer capabilities are also evident in projects with AMERIA (touchless control) and the various training and simulation projects with STIHL, where we built simulations and practical trainings for rapid skills development. These experiences translate directly to clinical workflow trainings, saw-simulator-like prototypes for medical devices and secure operator interfaces.

About Reruption

Reruption was founded to not only advise organizations, but to build real products and capabilities in-house with entrepreneurial ownership. Our co-preneur methodology means: we work like co-founders, not external observers — we take responsibility for implementation and operational impact.

For MedTech teams we therefore offer not just individual workshops, but a complete enablement ecosystem: from executive alignment through technical bootcamps to governance and compliance training — always with a focus on measurable results and auditable processes.

Would you like to integrate AI into your medical technology products safely?

Book a short preliminary conversation so we can understand your priorities and sketch a tailored enablement package.

What our Clients say

Hans Dohrmann

Hans Dohrmann

CEO at internetstores GmbH 2018-2021

This is the most systematic and transparent go-to-market strategy I have ever seen regarding corporate startups.
Kai Blisch

Kai Blisch

Director Venture Development at STIHL, 2018-2022

Extremely valuable is Reruption's strong focus on users, their needs, and the critical questioning of requirements. ... and last but not least, the collaboration is a great pleasure.
Marco Pfeiffer

Marco Pfeiffer

Head of Business Center Digital & Smart Products at Festool, 2022-

Reruption systematically evaluated a new business model with us: we were particularly impressed by the ability to present even complex issues in a comprehensible way.

AI Transformation in Medical Technology & Healthcare Devices

AI can fundamentally change the way medical devices are developed, tested and operated. But unlike many other industries, medical technology requires a much higher degree of traceability, risk assessment and regulatory integration. Our enablement approach targets exactly this intersection: we empower people to not only build prototypes, but to develop AI solutions that are documented, validated and auditable.

Industry Context

MedTech is characterized by long development cycles, regulatory reviews and a strong responsibility for patient safety. Decisions must be provable; errors can have potentially life-critical consequences. That means: enablement for this industry cannot stop at generic AI skills; it must focus on topics like verification strategies, documentation standards and risk mitigation.

In Baden-Württemberg, a MedTech hub with companies such as Aesculap, Karl Storz and Ziehm, product teams are often technically proficient but heterogeneous in their competencies around modern AI workflows. Therefore, our programs combine regional industry understanding with practical methodology: short, intensive bootcamps followed by sustained coaching in the product context.

Data protection, clinical validation and interfaces to hospital IT systems (e.g. HL7, DICOM) are daily requirements. Effective enablement integrates these technical standards into prompting frameworks, test plans and playbooks so teams can produce product-ready artifacts that meet regulatory requirements.

Key Use Cases

Documentation copilots are a central application area: AI-assisted assistants can pre-structure clinical reports, test documentation and approval dossiers, suggest cross-references and thus significantly shorten time to market readiness. In our trainings we show how to prompt such copilots correctly, how to validate outputs and how to establish audit trails.

Clinical workflow assistants support nursing and clinical staff directly at the point of care: from standardized examination protocols to suggestions for troubleshooting device malfunctions. Our bootcamps demonstrate how to train these assistants so they are ergonomic, explainable and safe — and which human control instances are necessary.

Regulatory alignment is not an afterthought but a core benefit: we teach how to construct validation workflows for ML models, which documentation requirements the MDR/IVDR impose and what an audit-ready model lifecycle must look like. This helps avoid delays in the approval process and significantly reduces regulatory risks.

Implementation Approach

Our enablement starts with Executive Workshops that synchronize governance, risk appetite and product strategy. Based on this, Department Bootcamps follow, tailoring content specifically for Quality Management, Regulatory Affairs, R&D and clinical teams. This creates a common language between decision-makers and implementers.

The AI Builder Track teaches technical basic competencies: data preparation, model inputs, prompts and simple validation routines. For medical device users we translate these topics into concrete artifacts like test cases, traceability matrices and documentation templates — all with the goal of generating quickly usable, audit-ready results.

Enterprise Prompting Frameworks and playbooks are not taught abstractly but created directly in the context of real tasks: e.g. a prompt template for creating test reports or a playbook for implementing a documentation copilot in the QMS. Our on-the-job coaches accompany teams until the tools are stably integrated into daily routines.

Success Factors

Successful AI enablement in MedTech hinges on three points: first clear governance, second practice-oriented training with immediate application, and third sustained support after training. Only then are reproducible, regulatorily sound results created.

We measure success not by slides, but by output: number of productive copilots, achieved time savings in documentation, reduction of manual review efforts and shortened time to technical verifiability. Typical time-to-value for the first audit-ready artifacts among our clients is a matter of weeks to a few months, depending on data maturity and organizational readiness.

Team composition is decisive: an interdisciplinary enablement team should include Regulatory Affairs, QA, Data Engineering and clinical experts. Change management ensures that new processes are accepted — we support with communication templates, internal Communities of Practice and leadership coaching to anchor the transformation.

Ready to enable your team for AI?

Request the program profile and start with an Executive Workshop to define governance and roadmap.

Frequently Asked Questions

Regulatory approvability starts with design decisions: models must not be treated as opaque black boxes, but should be developed from the outset with validation strategies, traceability and test protocols. In our programs we teach concrete methods for Model Governance, versioning and test documentation that meet the requirements of the MDR/IVDR and national authorities.

A pragmatic approach is to define validation stages: technical validation (performance, robustness), clinical validation (evidence of benefit) and regulatory documentation (risk assessment, instructions for use). Each stage receives clear acceptance criteria that are traceable in an audit.

It should also be noted that regulators increasingly expect algorithmic changes to be managed over the product lifecycle: we show what change-control processes for models look like, the role real-world evidence plays and how post-market monitoring must be set up.

Practically speaking this means: develop standardized templates for test reports, build audit trails into your data pipelines and establish a small interdisciplinary board to approve model changes. Our workshops provide templates, role plays and review checklists so teams can apply these processes immediately.

There is no one-size-fits-all: executives need strategic workshops for risk and prioritization evaluation, Regulatory Affairs requires in-depth compliance training, while R&D and data engineers need hands-on bootcamps for model validation. Our modules are therefore modular: Executive Workshops, Department Bootcamps and the AI Builder Track each address specific needs.

For Quality Management and Regulatory teams we focus on audit-readiness, documentation playbooks and risk assessments. For clinical users, usability, explainability and integration into clinical workflows are central — here we work with use-case-based simulations and role plays.

Less technically versed employees particularly benefit from the AI Builder Track: it provides enough technical understanding to write safe prompts, critically assess outputs and perform simple validation steps. This breaks down silos and improves collaboration between domain experts and engineering.

What matters is the combination of intensive learning phases and on-the-job coaching. We see the best results when a bootcamp is followed by supported work on real artifacts: a documentation copilot that is implemented and verified in parallel with the training sustainably underpins learning outcomes.

Data protection is central: before models are trained, it must be checked which data may actually be used. Anonymization, pseudonymization and data minimization are standard measures that we teach in our compliance workshops in a hands-on way. We work with concrete technical patterns to remove personal identifiers without destroying clinical signal value.

In addition, secure development environments are required: air-gapped training environments, controlled access rights and encrypted data pipelines are part of our technical recommendations. We advise on how to design infrastructure so it is auditable and GDPR-compliant.

For operational use we recommend monitoring and anomaly detection to detect unplanned model deviations early. Our on-the-job coaches show how to configure alerts, which logs should be retained for audits and what incident management looks like if sensitive data are affected.

Finally, clear documentation is required: decisions about data curation, bias mitigation and consent management must be traceable in writing. We provide templates and training so that these documentation obligations become standard practice rather than a burden.

Low-risk use cases are those that do not make clinical decisions autonomously but support humans: documentation copilots, assistance with report creation, automatic classification of technical error messages or predictive maintenance for device condition are typical examples. These applications deliver visible value with low regulatory risk.

A documentation copilot can, for example, pre-structure test protocols, suggest consistent phrasing and check completeness. Such tools accelerate processes and reduce errors without directly impacting clinical treatment — ideal for first enablement steps.

Assistants for clinical workflows that provide decision recommendations together with confidence transparency (explainability) and always require human sign-off are also suitable as entry points. In our bootcamps teams develop such prototypes and test their integration into existing SOPs.

It is important to define realistic success criteria: time savings in documentation, reduction of manual errors, or shortened turnaround times for regulatory documents. These KPIs make the initiative's value understandable to stakeholders and support further investment.

ROI measurement starts with clear, predefined KPIs: time saved in documentation processes, number of audit-ready artifacts, reduction of manual correction loops or reduced time-to-market for small feature releases. Our trainings include metrics workshops to define and operationalize these KPIs together with stakeholders.

Another important metric is adoption: how many teams regularly use the developed copilots or playbooks? Adoption can be measured through usage statistics, qualitative user surveys and observation of process integration. High adoption is often the best early indicator of long-term ROI.

We recommend a combined measurement strategy: quantitative KPIs supplemented by qualitative success measures (e.g. interviews, user feedback, audit reports). This way you capture technological improvements and regulatory wins together.

In many cases our clients see measurable effects after just a few months: fewer queries to Regulatory, lower correction rates and shorter creation times for test documentation. These results then serve as the business case for scaling enablement measures further.

A sustainable Community of Practice emerges through regular, relevant formats: brown-bag sessions, use-case presentations, joint code or prompt reviews and a central knowledge hub with playbooks and templates. In our programs we support the organizational and content-related development of such formats so that the exchange of best practices takes place continuously.

Fostering interdisciplinarity is important: members from Regulatory, QA, R&D, clinical practice and Data Science should be actively involved. This creates mutual understanding and concrete collaborations that go beyond single pilot projects.

Practical measures include setting up champions programs in which internal multipliers receive additional training, as well as regular hackdays or sprint formats in which concrete problems are solved in teams. Such formats create tangible results and motivate participation.

We also support the governance layer: role descriptions, decision paths for model changes and templates for review meetings ensure that the community not only shares knowledge but also establishes standardized, auditable processes.

Contact Us!

0/10 min.

Contact Directly

Your Contact

Philipp M. W. Hoffmann

Founder & Partner

Address

Reruption GmbH

Falkertstraße 2

70176 Stuttgart

Social Media